| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 12/23/2009 | WO2009152610A1 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof |
| 12/23/2009 | WO2009120396A3 Compositions and methods for regulating erythropoientin expression and ameliorating anemia and stimulating erythropoiesis |
| 12/23/2009 | EP1483297B1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 12/23/2009 | CN101611052A Multimeric FC receptor polypeptides including a modified FC domain |
| 12/23/2009 | CN101610785A 多价肺炎球菌多糖-蛋白质缀合物组合物 Multivalent pneumococcal polysaccharide - protein conjugate composition |
| 12/23/2009 | CN101607983A Encephalitis B virus PrM/M protein B cell antigen epitope polypeptide and applications |
| 12/22/2009 | US7635767 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 12/22/2009 | US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/22/2009 | US7635666 Methods for producing members of specific binding pairs |
| 12/22/2009 | US7635479 comprising fusion protein biodrug as antitumor agent; contains amino acid sequence from prokaryotic organism such as a Listeria species protein, an ActA protein, a Streptolysin protein; immunotherapy |
| 12/22/2009 | US7635478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/22/2009 | CA2523466C Probes for detection and quantification of lipid second messengers and a method for detecting and quantifying lipid second messengers |
| 12/17/2009 | WO2009152364A2 Proteins that fluoresce at infrared wavelengths or generates singlet oxygen upon illumination |
| 12/17/2009 | WO2009149562A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 12/17/2009 | WO2009149560A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | CA2727811A1 Conjugates for the administration of biologically active compounds |
| 12/17/2009 | CA2727141A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 12/17/2009 | CA2727086A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 12/17/2009 | CA2726768A1 Methods and compositions for generation of bax- and bak-deficient cell lines |
| 12/16/2009 | EP2133427A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 12/16/2009 | EP2133423A1 Germ cell marker using fish vasa gene |
| 12/16/2009 | EP2133100A1 MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof |
| 12/16/2009 | EP1407023B1 Group b streptococcus antigens and corresponding dna fragments |
| 12/16/2009 | EP1287147B1 Immunotoxin fusion proteins and means for expression thereof |
| 12/16/2009 | CN101605889A Fused protein containing insulin precursor of overexpression and secretion type, DNA encoding the same and method of producing insulin |
| 12/16/2009 | CN101605808A Recombinant antigens of human cytomegalovirus (HCMV) |
| 12/16/2009 | CN101602809A Antibody targeted complement inhibitor with anti-inflammatory action |
| 12/16/2009 | CN101602803A Preparation method of recombination human thymosin beta 16 |
| 12/15/2009 | US7632808 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system |
| 12/15/2009 | US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc |
| 12/15/2009 | US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 12/15/2009 | CA2345138C Polymer conjugates of interferon beta-1a and their uses |
| 12/15/2009 | CA2243088C Humanized green fluorescent protein genes and methods |
| 12/10/2009 | WO2009149083A2 Non-hemolytic clya for excretion of proteins |
| 12/10/2009 | WO2009148194A1 Polynucleotide for releasing recombinant protein to the outside of eukaryotic cell |
| 12/10/2009 | US20090306195 Fusion Proteins of Mycobacterium Tuberculosis |
| 12/10/2009 | US20090305411 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 12/10/2009 | US20090305350 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/10/2009 | US20090304713 Binding agents |
| 12/10/2009 | CA2726293A1 Non-hemolytic clya for excretion of proteins |
| 12/10/2009 | CA2726128A1 Cell line, system and method for optical control of secondary messengers |
| 12/09/2009 | EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 12/09/2009 | EP2130919A1 IL-21 antagonists |
| 12/09/2009 | EP2130840A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof |
| 12/09/2009 | EP2129687A2 Novel glp-1 fusion peptides, their production and use |
| 12/09/2009 | EP1558729B1 Rapidly degraded reporter fusion proteins |
| 12/09/2009 | EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/09/2009 | CN101597335A Recombined protein specially combined with fiber protein and application thereof |
| 12/09/2009 | CN100567495C Methods for large scale production of recombinant DNA-derived tPA or K2S molecules |
| 12/09/2009 | CN100567488C Enhancement of virus-mediated DNA transfer |
| 12/09/2009 | CN100567487C Coagulation factor VII derivatives |
| 12/09/2009 | CN100567325C VEGF receptor fusion protein and its use in preparation of medicament for treating eye disease |
| 12/08/2009 | US7629440 Comprises fusion proteins isolated from influenza virus hemagglutinin and colony stimulating factor |
| 12/08/2009 | US7629327 Chlamydia 60 Kda CRMP antigens and vaccine uses |
| 12/08/2009 | US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo |
| 12/08/2009 | US7629145 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 12/08/2009 | US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 12/08/2009 | US7628987 Vectors derived from antibodies for transferring substances into cells |
| 12/08/2009 | CA2510797C Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/08/2009 | CA2268143C Production of a multimeric protein by cell fusion method |
| 12/03/2009 | WO2009145489A2 Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component |
| 12/03/2009 | WO2009143689A1 A soluble tumor necrosis factor receptor mutant |
| 12/03/2009 | WO2009143565A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 12/03/2009 | US20090298755 Novel Chimeric Analgesic Peptides |
| 12/03/2009 | US20090297479 Dc-hil conjugates for treatment of t-cell disorders |
| 12/03/2009 | US20090297440 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/03/2009 | US20090297436 Antibodies to il-6 and use thereof |
| 12/03/2009 | CA2725613A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 12/03/2009 | CA2710040A1 A soluble tumor necrosis factor receptor mutant |
| 12/02/2009 | EP2128260A2 Modified TGF-beta superfamily proteins |
| 12/02/2009 | EP2128252A1 Fused protein containing insulin precursor of overexpression and secretion type, dna encoding the same and method of producing insulin |
| 12/02/2009 | EP2128249A1 Zinc oxide-binding antibody and use thereof |
| 12/02/2009 | EP2126055A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3. |
| 12/02/2009 | EP2125882A1 Tumor suppressor activating polypeptides and uses thereof |
| 12/02/2009 | CN101591667A Dectin-1 fusion protein expression vector and application thereof |
| 12/02/2009 | CN101591665A Slpa as a tool for recombinant protein and enzyme technology |
| 12/02/2009 | CN101591640A Method for inducing somatic cell to reprogram by penetrating stem cell transcription factor |
| 12/02/2009 | CN101591633A Culture medium used for culturing microbial expression heparanase |
| 12/02/2009 | CN101591397A Recombinant expression and application of long-acting thymosin alpha1 |
| 12/02/2009 | CN101591388A Soluble tumor necrosis factor (TNF) receptor mutant |
| 12/02/2009 | CN100563709C Novel targeted tissue factor antibody as anticoagulants |
| 12/02/2009 | CN100563707C Activation and inhibition of the immune system |
| 12/01/2009 | US7625742 Avian leukosis viruses and polypeptide display |
| 12/01/2009 | CA2107513C Fusion protein for prodrug activation |
| 11/26/2009 | WO2009142460A2 Antibody-peptide fused synergibody |
| 11/26/2009 | WO2009142307A1 Peptide capable of extending half-life of peptide of interest in plasma |
| 11/26/2009 | WO2009140795A1 A method and kit for purification of recombinant proteins using a self-cleaving ptotein intein |
| 11/26/2009 | WO2009125231A3 Anti-atheroma vaccine |
| 11/26/2009 | WO2009090493A3 Tlr4 decoy receptor protein |
| 11/26/2009 | US20090292113 Recombinant soluble Fc receptors |
| 11/26/2009 | CA2698582A1 Peptide having an extending action for half-life of object peptide in plasma |
| 11/26/2009 | CA2667177A1 Slpa as a tool for recombinant protein and enzyme technology |
| 11/25/2009 | EP2123754A1 CHIMERIC Fc RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR |
| 11/25/2009 | EP2123680A1 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |